Stage 0 breast cancer is the earliest form of the disease, found only in the milk ducts or lobules of the breast and not yet spread to surrounding tissue

Stage 0 is also called carcinoma in situ. The cells are abnormal and growing, but they have not broken through the wall of the duct or lobule into the fatty tissue of the breast. This distinction matters because it changes how doctors treat it and what your long-term outlook looks like.

There are two types of stage 0 breast cancer. Ductal carcinoma in situ (DCIS) means the abnormal cells are in the milk ducts. Lobular carcinoma in situ (LCIS) means they are in the milk-producing glands. DCIS is found more often and is considered more likely to become invasive cancer if left untreated. LCIS is sometimes treated as a high-risk marker rather than cancer itself, though approaches vary by doctor and institution.

Key Takeaways

  • Stage 0 breast cancer has not spread beyond the duct or lobule where it started, making it the earliest detectable form of the disease.
  • DCIS (ductal carcinoma in situ) and LCIS (lobular carcinoma in situ) are the two types, and they carry different risks of becoming invasive cancer.
  • Most stage 0 cancers are found by mammogram before any symptoms appear, often as microcalcifications or a suspicious area.
  • Treatment typically involves surgery, sometimes followed by radiation or hormone therapy, depending on the type and other factors.
  • Survival rates for stage 0 breast cancer are very high, with most people living many years after diagnosis and treatment.

How stage 0 breast cancer is found

Stage 0 breast cancer usually has no symptoms. You cannot feel it, and it does not cause pain or discharge. It is almost always discovered by mammogram—either a routine screening mammogram or one done because of another concern.

On a mammogram, stage 0 cancer often appears as a cluster of tiny white specks called microcalcifications, or sometimes as a small area of dense tissue. When radiologists see this pattern, they typically recommend a biopsy to determine whether the cells are cancerous. A biopsy involves taking a small sample of tissue with a needle or removing a small area surgically, then examining it under a microscope.

Because stage 0 cancer is caught so early, finding it depends almost entirely on screening. Women who do not have regular mammograms are less likely to be diagnosed with stage 0 cancer—not because they do not have it, but because it is not detected.

The difference between stage 0 and invasive breast cancer

The critical difference is the basement membrane—a thin layer of tissue that surrounds the duct or lobule. In stage 0 cancer, the abnormal cells have not broken through this membrane. In invasive breast cancer (stage 1 and beyond), they have, which means the cancer can spread to lymph nodes and other parts of the body.

This boundary matters for treatment decisions. Stage 0 cancer is treated less aggressively than invasive cancer because it has not yet shown the ability to spread. You typically will not need chemotherapy for stage 0 alone. You also will not need lymph node surgery, because the cancer has not reached the nodes.

However, stage 0 cancer can become invasive if not treated. That is why doctors recommend surgery to remove the abnormal tissue, and sometimes additional treatments to reduce the risk of recurrence.

Treatment options for stage 0 breast cancer

Surgery is the standard first step. The most common approach is lumpectomy (also called breast-conserving surgery), which removes the area of cancer and a margin of normal tissue around it while preserving most of the breast. Some people choose mastectomy—removal of the entire breast—either because the cancer is in multiple areas or because of personal preference.

After lumpectomy, radiation therapy is often recommended. Radiation uses high-energy beams to target any remaining abnormal cells in the breast tissue. Studies show that radiation after lumpectomy reduces the risk that cancer will return in the same breast. Mastectomy patients may or may not need radiation depending on the size and location of the cancer.

Hormone therapy (tamoxifen or aromatase inhibitors) is sometimes used if the cancer cells have receptors for estrogen. These drugs block estrogen from fueling any remaining cancer cells. Hormone therapy is not chemotherapy and works differently—it is taken as a pill, usually for five years, and has a different side effect profile.

Recurrence risk and long-term outlook

The risk that stage 0 cancer will return varies. For DCIS, studies show that without any treatment, about 25 to 30 percent of people will develop invasive cancer in the same breast within 10 years. With surgery alone, that risk drops to roughly 10 to 15 percent. Adding radiation lowers it further, to around 5 to 10 percent.

For LCIS, the picture is different. LCIS is sometimes considered a marker of increased risk rather than cancer that must be treated. Some doctors recommend close monitoring with mammograms and clinical exams rather than immediate surgery. Others recommend surgery to remove the area. The choice depends on other risk factors, your age, and your preferences.

Survival rates for stage 0 breast cancer are very high. The five-year survival rate is close to 100 percent. Most people diagnosed with stage 0 cancer live many years after treatment, often dying of other causes. Recurrence, when it happens, usually occurs within the first five to ten years after diagnosis.

Factors that influence treatment decisions

Your doctor will consider several factors when recommending treatment. The size of the abnormal area, whether it is DCIS or LCIS, the grade of the cells (how abnormal they look under the microscope), and whether hormone receptors are present all play a role. Your age, family history of breast cancer, and personal preferences also matter.

Some people with very small, low-grade DCIS may be candidates for active surveillance—close monitoring with mammograms and exams instead of immediate surgery. This approach is still being studied, and it is not standard care everywhere. If you are interested in this option, discuss it with your doctor.

Genetic testing may be recommended if you have a family history of breast cancer. Mutations in genes like BRCA1 and BRCA2 increase the risk of developing more cancer in the future, which can influence whether you choose lumpectomy or mastectomy.

Life after stage 0 breast cancer diagnosis

After treatment, follow-up care is important. You will need regular mammograms—usually every six to twelve months for the first few years, then annually. Your doctor will also do clinical breast exams. These appointments catch any recurrence early, when it is most treatable.

Many people experience anxiety after a stage 0 diagnosis, even though the prognosis is excellent. The diagnosis itself can feel frightening, and the word "cancer" carries weight. Support groups, counseling, and conversations with your medical team can help you process the experience and move forward.

Most people return to normal activities after recovery from surgery and, if applicable, radiation. Radiation typically takes five to six weeks of daily appointments, but each session lasts only a few minutes. Side effects are usually mild—some skin irritation or fatigue—and resolve after treatment ends.

Frequently Asked Questions

Does stage 0 breast cancer always turn into invasive cancer?

No. Without treatment, about 25 to 30 percent of DCIS cases become invasive within 10 years. With surgery and radiation, that risk drops to around 5 to 10 percent. Many people with treated stage 0 cancer never develop invasive disease.

Can I keep my breast if I have stage 0 cancer?

Yes. Lumpectomy (breast-conserving surgery) is the standard treatment for most stage 0 cancers. It removes the abnormal area and a margin of normal tissue while preserving the breast. Radiation after lumpectomy reduces recurrence risk. Mastectomy is an option but not required for most stage 0 cases.

Will I need chemotherapy for stage 0 breast cancer?

Chemotherapy is not standard treatment for stage 0 cancer alone. Because the cancer has not spread beyond the duct or lobule, chemotherapy is not necessary. You may have surgery, radiation, and possibly hormone therapy, but not chemotherapy.

What is the difference between DCIS and LCIS?

DCIS (ductal carcinoma in situ) is in the milk ducts and is considered more likely to become invasive cancer. LCIS (lobular carcinoma in situ) is in the milk-producing glands and is sometimes treated as a high-risk marker rather than cancer. Treatment approaches differ, and some doctors recommend monitoring LCIS rather than surgery.

How often do I need mammograms after treatment?

Most doctors recommend mammograms every six to twelve months for the first few years after treatment, then annually. Your doctor will give you a specific schedule based on your situation. Regular screening catches any recurrence early, when it is most treatable.